Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Apellis Pharmaceuticals Inc (NASDAQ: APLS) closed the day trading at $17.87 up 3.24% from the previous closing price of $17.31. In other words, the price has increased by $3.24 from its previous closing price. On the day, 2.9 million shares were traded. APLS stock price reached its highest trading level at $18.45 during the session, while it also had its lowest trading level at $17.52.
Ratios:
For a better understanding of APLS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 4.08. In the meantime, Its Debt-to-Equity ratio is 2.86 whereas as Long-Term Debt/Eq ratio is at 2.82.
On May 09, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $23.
On April 29, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $44.Cantor Fitzgerald initiated its Overweight rating on April 29, 2025, with a $44 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 16 ’25 when Watson David O. sold 5,000 shares for $18.77 per share. The transaction valued at 93,850 led to the insider holds 133,730 shares of the business.
Watson David O. bought 5,000 shares of APLS for $93,850 on Jun 16 ’25. On May 12 ’25, another insider, Townsend Adam J., who serves as the Former Officer of the company, bought 220,961 shares for $17.76 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 2245937408 and an Enterprise Value of 2282776832. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.89 while its Price-to-Book (P/B) ratio in mrq is 13.67. Its current Enterprise Value per Revenue stands at 2.942 whereas that against EBITDA is -12.378.
Stock Price History:
The Beta on a monthly basis for APLS is 0.66, which has changed by -0.4953403 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, APLS has reached a high of $42.47, while it has fallen to a 52-week low of $16.10. The 50-Day Moving Average of the stock is -1.42%, while the 200-Day Moving Average is calculated to be -31.02%.
Shares Statistics:
Over the past 3-months, APLS traded about 2.60M shares per day on average, while over the past 10 days, APLS traded about 1989010 shares per day. A total of 125.66M shares are outstanding, with a floating share count of 103.36M. Insiders hold about 17.76% of the company’s shares, while institutions hold 100.06% stake in the company. Shares short for APLS as of 1749772800 were 25140355 with a Short Ratio of 9.65, compared to 1747267200 on 27245432. Therefore, it implies a Short% of Shares Outstanding of 25140355 and a Short% of Float of 26.389998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
